With this regulatory matter satisfied, the companies now expect the transaction to close shortly following the receipt of approval of a majority of the votes cast by all Arrow shareholders who are entitled to vote and who are present in person or by proxy at the Arrow Annual Meeting on September 20, 2007.
* Permission to use quotation from Glass, Lewis was neither sought or
obtained.
About Arrow:
Arrow develops, manufactures and markets a broad range of clinically advanced, disposable catheters and related products for critical and cardiac care. The company's products are used primarily by anesthesiologists, critical care specialists, surgeons, emergency and trauma physicians, cardiologists, interventional radiologists and other healthcare providers. Arrow's news releases and other company information can be found on the World Wide Web at http://www.arrowintl.com. Arrow's common stock trades on the NASDAQ Global Select Market SM under the symbol ARRO.
Caution Concerning Forward-looking information:
This press release contains forward-looking statements, including the
anticipated timing for closing of the transaction. A further description of
these risks and uncertainties and other important factors that could cause
actual results to differ materially from Arrow's expectations can be found
Arrow's Annual Report on Form 10-K, as amended and in Arrow's other filings
with the SEC. The expectations and assumptions reflected in such forward
looking statements may prove incorrect. Arrow does not undertake to
publicly update or revise its forward-looking statements as a result of new
information, future event
'/>"/>
| SOURCE Arrow International, Inc. Copyright©2007 PR Newswire. All rights reserved |